LIVE MARKET TRACKER :   BSE SENSEX   19674.33   -387.91 -1.93%    |    NSE NIFTY 5967.05   -127.45 -2.09%  
GLOBAL MARKETS :  NASDAQ 3498.965   +0.97%    |    FSI London 6696.79   -2.10%    |    NIKKEI Japan 14900.25   +2.87%
  USD GBP EUR CAD AUD INR
USD - 0.663 0.7742 1.0329 1.0334 55.638
GBP 1.5086 - 1.168 1.5581 1.5589 83.9333
EUR 1.2918 0.8564 - 1.3343 1.3349 71.8748
CAD 0.9684 0.642 0.7498 - 1.0007 53.8799
AUD 0.9682 0.6419 0.7496 1.00 - 53.8687
INR 0.018 0.0119 0.0139 0.0186 0.0186 -

Oracle Unveils Latest Version In Banking Platform Oracle FLEXCUBE 12.0 (29-Jun-2012)

Indian-Commodity  :  Top News  :  Oracle Unveils Latest Version In Banking Platform Oracle FLEXCUBE 12.0
Oracle Unveils Latest Version In Banking Platform Oracle FLEXCUBE 12.0
Oracle has unveiled 'Oracle FLEXCUBE 12.0' to help banks meet the needs of Gen Y customers. Oracle FLEXCUBE 12.0 is the latest version of the Oracle FLEXCUBE banking platform. This new version includes features that enable banks to deliver more personalized and convenient service to customers across all channels. It also offers a harmonized infrastructure and open development environment that allows more flexible deployment options and upgrade paths.

Besides, the newest version provides financial institutions with expanded functionality for sales and self-service across multiple channels, including online, mobile, ATM and branch banking.

Further, Oracle FLEXCUBE 12.0 is qualified to run on Oracle Exadata Database Machine, Oracle Exalogic Elastic Cloud, and Oracle's SPARC T4 Servers and is pre-certified on a standard stack of Oracle Fusion Middleware, Oracle Database 11g and Oracle Database options including virtualization.

Oracle Financial Services Software is a majority owned subsidiary of Oracle. Oracle Corporation is the world's largest business software company.
Top News Today
Ranbaxy, L&T, SAIL, and Srei Infrastructure Finance may witnessed some action today
(23-May-2013)

Ranbaxy, L&T, SAIL, and Srei Infrastructure Finance may witnessed some action todayIndian generic giant Ranbaxy Laboratories has spent over $300 million to overhaul its operations and ensure no repeat of drug safety violations that led to a multi-million dollar US fine....

Govt reduces withholding tax on FIIs, QFIs interest income to 5% till 2015
(22-May-2013)

Govt reduces withholding tax on FIIs, QFIs interest income to 5% till 2015With an aim to provide broad based incentive and attract larger foreign institutional investors (FIIs) participation in the debt market, the government has slashed the withholding tax from...

ITC, JSPL, Maruti and Coal India may grab investors attention today
(22-May-2013)

ITC, JSPL, Maruti and Coal India may grab investors attention todayITC has overtaken Hindustan Unilever (HUL) in branded food and beverages sales, a decade after it entered the business, giving a shot in the arm to YC Deveshwar's ambition of making the cigarette...

International Stock News
Ben Bernanke's remark drag Asian markets lower in early deals
(23-May-2013)

Ben BernankeAsia pacific stocks are trading lower in early deals on Thursday on signs that the US Federal Reserve could soon start tapering off its massive stimulus measures after Federal Reserve Chief...

US markets slip on concern of Fed scaling back stimulus efforts
(23-May-2013)

US markets slip on concern of Fed scaling back stimulus effortsThe US markets slipped on Wednesday, reversing gains after minutes from the Federal Reserve's latest meeting and comments from the Fed chief suggested the central bank may begin tapering...

Asian markets end mostly higher ahead of Bernanke testimony
(22-May-2013)

Asian markets end mostly higher ahead of Bernanke testimonyAsian markets ended mostly higher on Wednesday, on buyers spree amid renewed optimism about the global economy following recent encouraging data from across the globe, ahead of testimony...

 

     
  
Recent Top News News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.